We believe that collaboration is a highly effective way to advance any treatment paradigm. We are excited to pursue collaboration opportunities, including the development of novel applications of our technology platform, RTGel™ reverse-thermal hydrogel, within urology, uro-oncology, and other therapeutic areas.
Are you interested in collaborating with UroGen?Contact us
Current development collaborations
In April 2019, UroGen entered into an agreement with Janssen Pharmaceuticals™ to conduct an early-stage feasibility evaluation in a therapeutic area of mutual interest.
UroGen and Janssen will each conduct certain activities under the terms of the agreement.